Skip to contentC
Catheter Precision, Inc.
C
VJETCatheter Precision, Inc. Q2 2024 · 10-Q
Revenue$93.00K$93.00K−3.1% vs Q2 2023 Net Income-$4.22M-$4.22MN/M vs Q2 2023 EPS, diluted—
Gross Profit$77,000−13.5% Operating Income-$2,717,000N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Catheter Precision, Inc. · CIK 1716621 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,697,000N/M Free Cash Flowderived-$1,742,000N/M Margins · derivedGross margin82.8%−9.9 pt vs Q2 2023
Operating margin-2921.5%+3649.3 pt vs Q2 2023
Net margin-4537.6%−2896.0 pt vs Q2 2023
ended Jun 30, 2024 · filed Aug 14, 2024 · 45 d after period end